Advertisement

Topics

Myriad Genetics Inc. Q4 Earnings Decline 21%

16:28 EDT 8 Aug 2017 | FinanzNachrichten

WASHINGTON (dpa-AFX) - Myriad Genetics Inc. (MYGN) released a profit for fourth quarter that dropped from last year.The company said its earnings fell to $20.8 million, or $0.30 per share. This wa...

Original Article: Myriad Genetics Inc. Q4 Earnings Decline 21%

NEXT ARTICLE

More From BioPortfolio on "Myriad Genetics Inc. Q4 Earnings Decline 21%"

Quick Search
Advertisement